乳腺癌PET/MRI中18F-FDG剂量降低的可行性
本研究纳入26例经组织学证实的乳腺癌女性患者,通过列表模式数据生成模拟剂量降低的PET图像,比较不同重建方式。结果显示,标准剂量的10%(降低≤90%)在飞行时间PET/MRI中获得临床可接受的图像质量,估算全身辐射负担为0.5±0.1 mSv。
要点
- 标准剂量10%的重建在图像质量、锐利度和噪声方面显著优于2分钟重建(P≤0.001)。
- 20%、10%和5%重建对原发灶检出与2分钟重建无显著差异。
- 10%剂量对应估算平均剂量22.6±5.5 MBq,全身辐射负担0.5±0.1 mSv。
核心结论
- 标准18F-FDG剂量的10%(降低≤90%)在飞行时间PET/MRI中获得临床可接受的PET图像质量。
- 计算的辐射暴露与单次数字乳腺X线摄影的有效剂量相当。
- 将辐射负担降低至该水平可能支持针对特定适应证的PET/MRI局部体部检查。
研究设计与样本
- 研究分析了26例连续的组织学证实乳腺癌女性患者,中位年龄51岁(范围34-83岁)。
- 通过卸载PET/MRI列表模式数据生成模拟剂量降低的PET图像。
- 采集的20分钟PET帧以5种方式重建:前2分钟3次迭代28个子集作为参考,以及模拟原始剂量100%、20%、10%和5%的重建。
主要发现
- 共评估355个病灶(71个病灶各有5种不同重建)。
- 20分钟100%注射剂量重建在所有类别中显示最佳结果。
- 对于总体图像质量与伪影、图像锐利度和噪声,模拟剂量20%和10%的重建显著优于2分钟重建(P≤0.001)。
- 20%、10%和5%重建对原发灶检出与2分钟重建无显著差异。
- 对于10%注射剂量,计算的平均剂量为22.6±5.5 MBq(范围17.9-36.9 MBq),估算全身辐射负担为0.5±0.1 mSv(范围0.4-0.7 mSv)。
关键数值与推荐
- 图像质量与伪影、图像锐利度、图像噪声和病灶检出能力采用4分制分析。
- 定性参数比较使用非参数Friedman检验(多样本)和Wilcoxon符号秩检验(配对样本)。
- 不同独立样本组比较使用Mann-Whitney U检验。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The goal of this study was to determine the level of clinically acceptable 18F-FDG dose reduction in time-of-flight PET/MRI in patients with breast cancer. Methods: Twenty-six consecutive women with histologically proven breast cancer were analyzed (median age, 51 y; range, 34-83 y). Simulated dose-reduced PET images were generated by unlisting the list-mode data on PET/MRI. The acquired 20-min PET frame was reconstructed in 5 ways: a reconstruction of the first 2 min with 3 iterations and 28 subsets for reference, and reconstructions simulating 100%, 20%, 10%, and 5% of the original dose. General image quality and artifacts, image sharpness, image noise, and lesion detectability were analyzed using a 4-point scale. Qualitative parameters were compared using the nonparametric Friedman test for multiple samples and the Wilcoxon signed-rank test for paired samples. Different groups of independent samples were compared using the Mann-Whitney U test. Results: Overall, 355 lesions (71 lesions with 5 different reconstructions each) were evaluated. The 20-min reconstruction with 100% injected dose showed the best results in all categories. For general image quality and artifacts, image sharpness, and noise, the reconstructions with a simulated dose of 20% and 10% were significantly better than the 2-min reconstructions (P ≤ 0.001). Furthermore, 20%, 10%, and 5% reconstructions did not yield results different from those of the 2-min reconstruction for detectability of the primary lesion. For 10% of the injected dose, a calculated mean dose of 22.6 ± 5.5 MBq (range, 17.9-36.9 MBq) would have been applied, resulting in an estimated whole-body radiation burden of 0.5 ± 0.1 mSv (range, 0.4-0.7 mSv). Conclusion: Ten percent of the standard dose of 18F-FDG (reduction of ≤90%) results in clinically acceptable PET image quality in time-of-flight PET/MRI. The calculated radiation exposure would be comparable to the effective dose of a single digital mammogram. A reduction of radiation burden to this level might justify partial-body examinations with PET/MRI for dedicated indications.
引用
- Sah BR, Ghafoor S, Burger IA, et al. Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI. J Nucl Med. 2018. PMID: 29880506. doi:10.2967/jnumed.118.209007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。